FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
In a report released on November 1, Thomas Smith from SVB Securities maintained a Buy rating on Axcella Health (AXLA - Research Report), with a...
In a report released today, Robert LeBoyer from Noble Financial reiterated a Buy rating on Axcella Health (AXLA - Research Report), with a price...
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Unity Biotechnology (UBX β Research Report) and...
2022Q3false0001633070--12-3100016330702022-01-012022-09-3000016330702022-10-28xbrli:shares00016330702022-09-30is...
0001633070FALSE00016330702022-11-012022-11-01UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 _____________________FORM...
One of the major owners of Axcella Health (NASDAQ:AXLA) engaged in a huge insider buy transaction yesterday. Societe des Produits Nestle...
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE...
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.